Recurrent candidaemia in a neonate with Hirschsprung's disease: Fluconazole resistance and genetic relatedness of eight Candida tropicalis isolates

Journal of Medical Microbiology

Volumn 55, Issue 4, 2006, Pages 423-428

  Chong, Pei Pei ^a   Chieng, David Ching Soo ^a   Low, Lee Yean ^a   Hafeez, Asma ^b   Shamsudin, Mariana Nor ^a   Seow, Heng Fong ^a   Ng, Kee Peng ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE; FUNGAL DNA; IMIPENEM; METRONIDAZOLE; RNA 28S; VANCOMYCIN;

AGAR GEL ELECTROPHORESIS; ANTIBIOTIC THERAPY; ARTICLE; CANDIDA TROPICALIS; CANDIDIASIS; CASE REPORT; DNA FINGERPRINTING; ENTEROBACTER; FUNGUS CULTURE; FUNGUS ISOLATION; GENETIC VARIABILITY; HIRSCHSPRUNG DISEASE; HUMAN; ILEOSTOMY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; SEPSIS; SPECIES IDENTIFICATION; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; CANDIDA TROPICALIS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGEMIA; HIRSCHSPRUNG DISEASE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; VARIATION (GENETICS);

EID: 33645464797     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46045-0     Document Type: Article

References (26)

1. Armstrong, J., Gibbs, A., Peakall, R. & Weiller, G. (1994). The RAPDistance package. http://www.rsbs.anu.edu.au/Products& Servi ces/BiotechnologyTransferUnit/rapdistance.asp
2. Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S. & Scalise, G. (2000). Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 44, 1578-1584.
3. Boschman, C. R., Bodnar, U. R., Tornatore, M. A., Obias, A. A., Noskin, G. A., Englund, K., Postelnick, M. A., Suriano, T. & Peterson, L. R. (1998). Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center. Antimicrob Agents Chemother 42, 734-738.
4. Bougnoux, M. E., Dupont, C., Mateo, J., Saulnier, P., Faivre, V., Payen, D. & Nicolas-Chanoine, M. H. (1999). Serum is more suitable than whole blood for diagnosis of systemic candidiasis by nested PCR. J Clin Microbiol 37, 925-930.
5. Chong, P. P., Lee, Y. L., Tan, B. C. & Ng, K. P. (2003). Genetic relatedness of Candida strains isolated from women with vaginal candidiasis in Malaysia. J Med Microbiol 52, 657-666.
6. Clancy, C. J., Barchiesi, F., Falconi Di Francesco, L., Morris, A. J., Snydman, D. R., Yu, V. L., Scalise, G. & Nguyen, M. H. (2000). Clinical manifestations and molecular epidemiology of late recurrent candidemia, and implications for management. Eur J Microbiol Infect Dis 19, 585-592.
7. Dice, L. R. (1945). Measures of the amount of ecologic associations between species. Ecology 26, 297-302.
8. Ellis, M. (2001). Invasive fungal infections: evolving challenges for diagnosis and therapeutics. Mol Immunol 38, 947-957.
9. Hu, K. K., Lipsky, B. A., Veenstra, D. L. & Saint, S. (2004). Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control 32, 142-146.
10. Kao, A. S., Brandt, M. E., Pruitt, W. R. & 9 other authors (1999). The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 29, 1164-1170.
11. Kontoyiannis, D. P., Vaziri, I., Hanna, H. A., Boktour, M., Thornby, J., Hachem, R., Bodey, G. P. & Raad, I. I. (2001). Risk factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 33, 1676-1681.
12. Krcmery, V., Jr, Oravcova, E., Spanik, S. & 8 other authors (1998). Nosocomial breakthrough fungemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother 41, 373-380.
13. Kumar, S., Tamura, K., Jakobsen, I.-B. & Nei, M. (2001). MEGA2: molecular evolutionary genetic analysis software. Bioinformatics 17, 1244-1245.
14. Metzgar, D., Van Belkum, A., Field, D., Haubrich, R. & Wills, C. (1998). Random amplification of polymorphic DNA and microsatellite genotyping of pre- and post-treatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens. J Clin Microbiol 36, 2308-2313.
15. NCCLS (2000). Performance standards for antimicrobial disk susceptibility tests. Approved standard, 7th edn. NCCLS document M2-A7. Wayne, PA: NCCLS.
16. NCCLS (2002). Performance standards for antimicrobial disk susceptibility tests. Twelfth informational supplement. NCCLS document M100-S12. Wayne, PA: NCCLS.
17. Ng, K. P., Madasamy, M., Saw, T. L., Baki, A., He, J. & Soo-Hoo, T. S. (1999). Candida biotypes isolated from clinical specimens in Malaysia. Mycopathologia 144, 135-140.
18. Ng, K. P., Saw, T. L., Na, S. L. & Hoo, T. S. (2001). Systemic Candida infection in University Hospital 1997-1999: the distribution of Candida biotypes and antifungal susceptibility patterns. Mycopathologia 149, 141-146.
19. Nguyen, M. H., Peacock, J. E., Jr, Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G. & Yu, V. L. (1996). The changing face of candidemia: emergence of non-Candida albicans and antifungal resistance. Am J Med 100, 617-623.
20. Pfaller, M. A., Jones, R. N. & Doern, G. V. (2000). Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. The Sentry Participant Group. Antimicrob Agents Chemother 44, 747-751.
21. Roilides, E., Farmaki, E., Evdoridou, J. & 7 other authors (2003). Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 41, 735-741.
22. Walsh, T. J. & Merz, W. G. (1986). Pathogenic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am J Clin Pathol 85, 498-502.
23. Weinberger, M., Sacks, T., Sulkes, J., Shapiro, M. & Polacheck, I. (1997). Increasing fungal isolation from clinical specimens: experience in a university hospital over a decade. J Hosp Infect 35, 185-195.
24. White, T. J., Burns, T. D., Lee, S. B. & Taylor, J. W. (1990). Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In PCR Protocols, pp. 315-322. Edited by M. A. Innis, D. H. Gelfrand, J. J. Sninsky & T. J. White. San Diego: Academic Press.
25. Wingard, J. R. (1995). Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20, 115-175.
26. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E. & Saral, R. (1991). Increase in Candida krusei infection among patients with bone marrow transplant and neutropenia treated prophylactically with fluconazole. N Engl J Med 325, 1274-1277.